DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Fenaux P, Mufti GJ, Hellstrom-Lindberg E et al.
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
The Lancet Oncology 2009;
10: 223-232
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.